Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DVUC | ISIN: NZAFTE0001S4 | Ticker-Symbol:
Branche
Versorger
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
AFT PHARMACEUTICALS LIMITED Chart 1 Jahr
5-Tage-Chart
AFT PHARMACEUTICALS LIMITED 5-Tage-Chart

Aktuelle News zur AFT PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
AFT PHARMACEUTICALS Aktie jetzt für 0€ handeln
DoAFT PHARMACEUTICALS LIMITED: Disclosure of Directors and Senior Managers Relevant Interes-
DoAFT PHARMACEUTICALS LIMITED: Disclosure of Directors and Senior Managers Relevant Intere-
DoAFT PHARMACEUTICALS LIMITED: Notice of Annual Meeting of Shareholders 2025-
DiAFT PHARMACEUTICALS LIMITED: Update - Dividend/Distribution - AFP-
DiAFT PHARMACEUTICALS LIMITED: Update - Dividend/Distribution - AFP-
03.06.AFT Pharmaceuticals - Setting the stage for sustained long-term growth312AFT Pharmaceuticals reported FY25 revenues of N Z$208m, posting a strong recovery in H2, with dissipating headwinds and traditional H2 seasonality offsetting the softer H1 performance. H225 revenues...
► Artikel lesen
29.05.AFT PHARMACEUTICALS LIMITED: Annual Meeting and Closing Date for Director Nominations-
26.05.Reshaped Combogesic deal sets 'pleased' AFT Pharma up to answer US demand2
22.05.HYLORIS: Hyloris Announces License Deal with AFT Pharmaceuticals for XTRAZA2
22.05.Health Check: 'Forgotten' drug maker AFT Pharma aims high with revenue1
22.05.Hot Stocks: Dexus, AFT Pharmaceuticals, Australian Agricultural Company3
22.05.AFT Pharma sets new $300M target after reaching $200M revenue for FY252
22.05.AFT PHARMACEUTICALS LIMITED: Corrected Distribution Notice-
21.05.AFT PHARMACEUTICALS LIMITED: AFT sees strong FY 26 as revenue reaches new record-
14.05.Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals8
30.04.AFT PHARMACEUTICALS LIMITED: AFT to announce full year results on Thursday May 22 2025-
29.11.24AFT Pharmaceuticals - Softer H1 on one-offs; recovery expected in H2329AFT Pharmaceuticals reported H125 revenues of NZ$86.7m, a 3.7% y-o-y increase, albeit lower than expected due to one-off factors such as inventory rationalisation by certain international customers...
► Artikel lesen
04.11.24AFT Pharmaceuticals - H125 profitability weighed down by one-offs296AFT Pharmaceuticals has released a trading update ahead of its H125 results, expecting to report a c NZ$2m operating loss for the period ending September 2024, driven by one-off factors affecting the...
► Artikel lesen
30.09.24AFT Pharmaceuticals - Maxigesic IV reaches the Chinese shores224AFT Pharmaceuticals has taken another major step in extending its international footprint, with the signing of an exclusive license agreement for Maxigesic IV in China, the second-largest pharma market...
► Artikel lesen
09.08.24AFT Pharmaceuticals - Hikma partnership expands to include Combogesic385AFT Pharmaceuticals has expanded its licensing partnership with Hikma in the US to include distribution of the recently launched Combogesic tablets (Maxigesic Rapid). We view this as a logical step...
► Artikel lesen
Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1